Compare
5 stocks, side by sideRelative performance · rebased to 100
RXRXTSHACAPRSNDXZYME
| RXRXRecursion Pharmaceuticals, Inc. | TSHATaysha Gene Therapies, Inc. | CAPRCapricor Therapeutics, Inc. | SNDXSyndax Pharmaceuticals, Inc. | ZYMEZymeworks Inc. | |
|---|---|---|---|---|---|
| Smart Score | 1/10 | 4/10 | 1/10 | 3/10 | 5/10 |
| Price | $3.44 | $5.48 | $9.06 | $19.95 | $28.14 |
| 1 month | +8.3% | -14% | +116% | +0.94% | +21% |
| 1 year | -38% | +87% | +18% | +26% | +100% |
| 5 year | -87% | -69% | +105% | +28% | -13% |
| P/E (TTM) | -3.0 | -14.4 | -3.9 | -7.2 | -20.5 |
| P/E vs sector | - | - | - | - | - |
| Market cap | $1.8B | $1.8B | $1.8B | $1.8B | $1.7B |
| Sector | Healthcare | Healthcare | Healthcare | Healthcare | Healthcare |
Risk / Return · past yearAnnualized return vs volatility, up-and-left is more reward for less risk.
Correlation · do they move together?Pairwise daily-return correlation over the past year, high = one bet, low = diversifying.